(4R)-N-[2-(2-methoxyethoxy)ethyl]-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-7-methoxy-3,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide

C31H55NO4 — CID 157174465

IUPAC(4R)-N-[2-(2-methoxyethoxy)ethyl]-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-7-methoxy-3,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide
SMILESCOCCOCCNC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3[C@H](OC)C[C@@H]4C[C@H](C)CC[C@]4(C)[C@H]3CC[C@]12C
InChIInChI=1S/C31H55NO4/c1-21-11-13-30(3)23(19-21)20-27(35-6)29-25-9-8-24(31(25,4)14-12-26(29)30)22(2)7-10-28(33)32-15-16-36-18-17-34-5/h21-27,29H,7-20H2,1-6H3,(H,32,33)/t21-,22-,23+,24-,25+,26+,27-,29+,30+,31-/m1/s1
InChIKeyOLOQHDBPGFDUIY-PTFROPORSA-N
MW505.78 g/mol
LogP6.10
Rot. Bonds11

About (4R)-N-[2-(2-methoxyethoxy)ethyl]-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-7-methoxy-3,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide

(4R)-N-[2-(2-methoxyethoxy)ethyl]-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-7-methoxy-3,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide (PubChem CID 157174465) has the molecular formula C31H55NO4 and a molecular weight of 505.78 g/mol. Its IUPAC name is (4R)-N-[2-(2-methoxyethoxy)ethyl]-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-7-methoxy-3,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide.

Molecular Properties

Compound Name(4R)-N-[2-(2-methoxyethoxy)ethyl]-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-7-methoxy-3,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide
PubChem CID157174465
Molecular FormulaC31H55NO4
Molecular Weight505.78 g/mol
Exact Mass505.41
IUPAC Name(4R)-N-[2-(2-methoxyethoxy)ethyl]-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-7-methoxy-3,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide
SMILESCOCCOCCNC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3[C@H](OC)C[C@@H]4C[C@H](C)CC[C@]4(C)[C@H]3CC[C@]12C
InChIInChI=1S/C31H55NO4/c1-21-11-13-30(3)23(19-21)20-27(35-6)29-25-9-8-24(31(25,4)14-12-26(29)30)22(2)7-10-28(33)32-15-16-36-18-17-34-5/h21-27,29H,7-20H2,1-6H3,(H,32,33)/t21-,22-,23+,24-,25+,26+,27-,29+,30+,31-/m1/s1
InChIKeyOLOQHDBPGFDUIY-PTFROPORSA-N
XLogP6.10
TPSA56.79 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds11
Heavy Atoms36
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500505.78
LogP ≤ 56.10
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze (4R)-N-[2-(2-methoxyethoxy)ethyl]-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-7-methoxy-3,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (4R)-N-[2-(2-methoxyethoxy)ethyl]-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-7-methoxy-3,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide?
The IUPAC name of (4R)-N-[2-(2-methoxyethoxy)ethyl]-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-7-methoxy-3,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide (CID 157174465) is (4R)-N-[2-(2-methoxyethoxy)ethyl]-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-7-methoxy-3,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide.
What is the SMILES notation for (4R)-N-[2-(2-methoxyethoxy)ethyl]-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-7-methoxy-3,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide?
The canonical SMILES for (4R)-N-[2-(2-methoxyethoxy)ethyl]-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-7-methoxy-3,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide is COCCOCCNC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3[C@H](OC)C[C@@H]4C[C@H](C)CC[C@]4(C)[C@H]3CC[C@]12C.
What is the InChIKey of (4R)-N-[2-(2-methoxyethoxy)ethyl]-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-7-methoxy-3,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide?
The InChIKey is OLOQHDBPGFDUIY-PTFROPORSA-N. The full InChI is InChI=1S/C31H55NO4/c1-21-11-13-30(3)23(19-21)20-27(35-6)29-25-9-8-24(31(25,4)14-12-26(29)30)22(2)7-10-28(33)32-15-16-36-18-17-34-5/h21-27,29H,7-20H2,1-6H3,(H,32,33)/t21-,22-,23+,24-,25+,26+,27-,29+,30+,31-/m1/s1.
What are the key properties of (4R)-N-[2-(2-methoxyethoxy)ethyl]-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-7-methoxy-3,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide?
(4R)-N-[2-(2-methoxyethoxy)ethyl]-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-7-methoxy-3,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide has a molecular weight of 505.78 g/mol, XLogP of 6.10, 11 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for (4R)-N-[2-(2-methoxyethoxy)ethyl]-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-7-methoxy-3,10,13-trimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide is sourced from PubChem (CID 157174465), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).